| Acronym/Abbreviation | Explanation |
| 17β-HSD | 17β-hydroxysteroid dehydrogenase |
| 2-OHE2 | 2-hydroxy oestradiol |
| 4-OHE2 | 4-hydroxy oestradiol |
| 8-PN | 8-Prenylnaringenin |
| ACTH | adrenocorticotropic hormone |
| AhR | aryl hydrocarbon receptor |
| AR | androgen receptors |
| BCP | benzyl cyclohexyl phthalate |
| BOP | butyl octyl phthalate |
| BPA | bisphenol A |
| BPS | bisphenol S |
| CBG | cortisol-binding globulin |
| DDT | dichlorodiphenyltrichloroethane |
| DHEP | di(2-ethylhexyl) phthalate |
| E1 | oestrone |
| E2 | oestradiol (17β-oestradiol) |
| E3 | oestriol |
| E4 | oestetrol |
| ECS | endocannabinoid system |
| EE | ethinyl oestradiol |
| EDCs | chemicals disrupt endocrine functions |
| Erα/ESR1 | oestrogen receptor 1/oestrogen receptor α |
| Erβ/ESR2 | oestrogen receptor 2/oestrogen receptor β |
| EREs | oestrogen response elements |
| FSH | follicle-stimulating hormone |
| GnRH | gonadotropin-releasing hormone |
| GM-CSF | colony-stimulating factor |
| GR | glucocorticoid receptors |
| GPER | G protein-coupled oestrogen receptor 1 |
| HRT | hormone replacement therapy |
| HSP | heat shock proteins |
| IFNγ | interferonγ |
| IL-1, IL-6 | interleukin 1 and 6 |
| IL-8 | interleukin 8 |
| IGF-1 | insulin-like growth factor 1 |
| MAPK | mitogen-activated protein kinase |
| MMPs/TIMPs | matrix metalloproteinases and enhance the action of MMP inhibitors |
| MS | multiple sclerosis |
| NO | nitric oxide |
| NP | 4-para-nonylphenol |
| OPEs | organic phosphoric acid esters |
| PCBs | polychlorinated biphenyls |
| PCOS | polycystic ovary syndrome |
| PET | positron emission tomography |
| PTH | parathormone |
| RA | rheumatoid arthritis |
| RFLP | restriction fragment length polymorphism |
| SAD | seasonal affective disorder |
| SLE | systemic lupus erythematosus |
| SNPs | single nucleotide polymorphisms |
| TH | thyroid hormone (triiodothyronine, T3) |
| TGFβ | transforming growth factor β |
| T3 | triiodothyronine |
| TNFα | tumour necrosis factor α |
| TPHP | triphenyl phosphate |
| TOCP | tri-o-cresyl phosphate |
| VEGF | vascular endothelial growth factor |
| VTE | venous thromboembolism (includes DVT and PE) |
| VMN | hypothalamus’s ventromedial nucleus |